Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)
NCT04636775
·
clinicaltrials.gov ↗
UNKNOWN
Status
46
Enrollment
OTHER
Sponsor class
Conditions
NSCLC Stage IV
NSCLC, Recurrent
Interventions
DIAGNOSTIC_TEST:
Microbiome
Sponsor
Jun Zhang, MD, PhD